9 Best Labor Day Sales of 2016

jamelkenya.com
Shares of Becton, Dickinson (NYSE: BDX ) were flat in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 15.71% over the past year to $2.79, which beat the estimate of $2.52. Revenue of $4,784,000,000 higher by 4.36% year over year, which beat the estimate of $4,480,000,000. Outlook The upcoming fiscal years EPS expected to be between $12.40 and $12.60. Conference Call Details Date: Nov 05, 2020 View more earnings on BDX Time: 08:00 AM ET Webcast URL: https://edge.media-server.com/mmc/p/jkuhzjuq Technicals 52-week high: $286.72 52-week low: $197.75 Price action over last quarter: down 7.65% Company Profile Becton, Dickinson is the worlds largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the companys business. See more from Benzinga Click here for options trades from Benzinga Recap: Linde Q3 Earnings Recap: AstraZeneca Q3 Earnings © 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View comments
Maximizing Your Chances: Strategies for Winning in Math Games
Discover techniques to enhance your winning odds in math games through strategic number selection and probability understanding.